InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.720
0.00 (0.00%)
May 26, 2026, 12:49 PM EDT - Market open
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $7.68 million as of May 26, 2026. Its market cap has increased by 176.56% in one year.
Market Cap
7.68M
Enterprise Value
2.90M
1-Year Change
176.56%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since May 6, 2014, InMed Pharmaceuticals's market cap has decreased from $9.40M to $7.68M, a decrease of -18.31%. That is a compound annual growth rate of -1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 7.68M | 83.19% |
| Dec 31, 2025 | 4.19M | 22.12% |
| Dec 31, 2024 | 3.43M | 57.02% |
| Dec 29, 2023 | 2.19M | -31.94% |
| Dec 30, 2022 | 3.21M | -82.66% |
| Dec 31, 2021 | 18.52M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aytu BioPharma | 22.92M |
| Apimeds Pharmaceuticals US | 18.36M |
| Akanda | 12.96M |
| China SXT Pharmaceuticals | 10.78M |
| Biofrontera | 9.84M |
| Caring Brands | 9.82M |
| cbdMD | 7.82M |
| RedHill Biopharma | 5.11M |